0001209191-17-030369.txt : 20170505
0001209191-17-030369.hdr.sgml : 20170505
20170505165049
ACCESSION NUMBER: 0001209191-17-030369
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170504
FILED AS OF DATE: 20170505
DATE AS OF CHANGE: 20170505
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: INTEGRA LIFESCIENCES HOLDINGS CORP
CENTRAL INDEX KEY: 0000917520
STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826]
IRS NUMBER: 510317849
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 311 ENTERPRISE DRIVE
CITY: PLAINSBORO
STATE: NJ
ZIP: 08536
BUSINESS PHONE: 6092750500
MAIL ADDRESS:
STREET 1: 311 ENTERPRISE DRIVE
CITY: PLAINSBORO
STATE: NJ
ZIP: 08536
FORMER COMPANY:
FORMER CONFORMED NAME: INTEGRA LIFESCIENCES CORP
DATE OF NAME CHANGE: 19950614
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SULLIVAN JAMES M
CENTRAL INDEX KEY: 0001210128
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-26224
FILM NUMBER: 17819092
MAIL ADDRESS:
STREET 1: 311 ENTERPRISE DR
CITY: PLAINSBORO
STATE: NJ
ZIP: 08536
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-05-04
0
0000917520
INTEGRA LIFESCIENCES HOLDINGS CORP
IART
0001210128
SULLIVAN JAMES M
311 C ENTERPRISE DR
PLAINSBORO
NJ
08536
1
0
0
0
Common Stock
2017-05-04
4
M
0
15658
10.74
A
70154
D
Common Stock
2017-05-04
4
S
0
15658
45.8918
D
54496
D
Non-Qualified Stock Option (right to buy)
10.74
2017-05-04
4
M
0
15658
0.00
D
2017-05-20
Common Stock
15658
0
D
The price shown above represents the weighted average price of the shares sold. The range of sale prices was $45.83 to $45.97.
25% of the stock options vest every quarter from the grant date of 05/20/2009.
This stock option was previously reported as covering 7,829 shares of common stock at an exercise price of $21.48 per share. In accordance with the terms of the stock option plan, the exercise price of the option and number of shares subject to the option have been adjusted to reflect the two-for-one stock split that occurred on December 21, 2016.
/s/ Richard D. Gorelick; Attorney-in-Fact
2017-05-05